✦ LIBER ✦

Cost Utility of Telaprevir–PR (Peginterferon–Ribavirin) Versus Boceprevir–PR and Versus PR Alone in Chronic Hepatitis C in The Netherlands

✍ Scribed by Vellopoulou, Aikaterini; van Agthoven, Michel; van der Kolk, Annemarie; de Knegt, Robert J.; Berdeaux, Gilles; Cure, Sandrine; Bianic, Florence; Lamotte, Mark

Book ID: 127191916
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2014
Tongue: English
Weight: 823 KB
Volume: 12
Category: Article
ISSN: 1175-5652
DOI: 10.1007/s40258-014-0120-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Telaprevir Plus Pe

Cost-Effectiveness of Telaprevir Plus Peginterferon/Ribavirin (TVR+PR) Versus Peginterferon/Ribavirin (PR) in Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients with F2 Fibrosis in Brazil

✍ Morais, A.D.; Pereira, M.L. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PIN61 The Cost-Utility of Telaprevir in

PIN61 The Cost-Utility of Telaprevir in Combination With Peginterfeon Alpha and Ribavirin (PR) as Compared to the Combination Boceprevir With PR and to PR Alone in the Management of Chronic Hepatitis C in the Netherlands

✍ K. Vellopoulou; M. Van Agthoven; A. Van Der Kolk; M. Lamotte; S. Cure; F. Bianic 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PGI16 Cost Effectiveness of Boceprevir P

PGI16 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients

✍ M. Fonseca; V. Garran; G.T. Araujo 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

826 SAFETY AND EFFICACY OF TWICE DAILY V

826 SAFETY AND EFFICACY OF TWICE DAILY VERSUS EVERY 8 HOUR TELAPREVIR WITH PEGINTERFERON/RIBAVIRIN (PR) IN PATIENTS WITH CIRRHOSIS

✍ Horsmans, Y.; Brown, R.S.; Buti, M.; Agarwal, K.; Sievert, W.; Janczewska, E.; Z 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 74 KB

PGI21 Cost Effectiveness of the Combinat

PGI21 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Retreatment of Patients With Chronic Hepatitis C Virus Genotype I Infection

✍ M. Fonseca; V. Garran; G.T. Araujo 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PGI25 Cost Effectiveness of Boceprevir P

PGI25 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients

✍ M. Fonseca; G. Tannus; E. Parisi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB